Vineet Labs Clarifies Financial Results Date Error, Board Approved Results on Aug 25, 2026
Vineet Laboratories Limited corrected a typo in its Q4 FY26 results, confirming board approval on August 25, 2026, not May 30, 2026. The company approved audited standalone financial results and statements for the year ended March 31, 2026, with an unmodified audit opinion. Total assets were ₹12,478.34 lakh, and it reported a profit before tax of ₹128.27 lakh for FY26.
The announcement is a correction of a minor typographical error regarding the date of board approval. It does not impact the company's financial performance, operations, or strategic outlook.
The announcement is a clarification of a typographical error in a previous filing. While it corrects a factual inaccuracy, it does not introduce new positive or negative financial information or business developments.
Vineet Laboratories Limited has issued a clarification regarding a typographical error in its Audited Financial Results for the quarter and year ended March 31, 2026. The error was in Note (a) of the financial results, where the date of approval by the Board of Directors was incorrectly stated as May 30, 2026, instead of the actual approval date of August 25, 2026.
The company confirmed that the Audit Committee reviewed and recommended, and subsequently, the Board of Directors approved the Audited Financial Results for the quarter and year ended March 31, 2026, at their respective meetings held on August 25, 2026.
A revised and corrected Statement of Audited Financial Results has been attached and submitted for perusal and record. Separately, the company announced the outcome of its Board Meeting held on August 25, 2026. The Board approved the Audited Standalone Financial Results for the fourth quarter and the financial year ended March 31, 2026, along with the Audited Standalone Financial Statement and Audit Report. A declaration of an unmodified audit opinion was also provided. Details of outstanding and incremental qualified borrowings for the financial year ended March 31, 2025, were also disclosed. The Board Meeting commenced at 3:00 PM and concluded at 6:30 PM on August 25, 2026.
As of March 31, 2026, the company reported total assets of ₹12,478.34 lakh and total equity and liabilities of ₹12,478.34 lakh. Equity share capital stood at ₹1,920.63 lakh, with other equity at ₹2,639.57 lakh. Non-current liabilities were ₹1,189.66 lakh, and current liabilities were ₹6,728.48 lakh. The company's cash flow statement for the year ended March 31, 2026, shows a profit before tax of ₹128.27 lakh, a significant improvement from a loss of ₹2,077.55 lakh in the previous year. Net cash generated from operating activities was ₹(1,203.19) lakh. The company also reported an issuance of shares amounting to ₹2,908.18 lakh and net cash generated from financing activities of ₹2,974.34 lakh.
A plain-language summary of a public exchange filing by Vineet Laboratories Limited. Read the original for the full detail.